Helicobacter pylori Treatment for Gastric Cancer Prevention.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

1. Population Attributable Fraction of Helicobacter pylori Infection-Related Gastric Cancer in Korea: A Meta-Analysis.Cancer research and treatment · 2021
   Pooled it
2. Optimized dual therapy for treatment-naive patients of Helicobacter pylori infection: A large-scale prospective, multicenter, open-label, randomized controlled study.Helicobacter · 2022
   Trial
3. Causal effects of drug exposure on gastric cancer risk: a Mendelian randomization study involving 23 commonly used medications in the European population.Discover oncology · 2026
   Article
4. Clinicopathological Profiles and Survival Outcomes of Patients with Gastric Cancer According to the Borrmann Endoscopic Classification: A Single-Center Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2025
   Article
5. Why internists should care about Helicobacter pylori: recapitulating gastric cancer prevention.Internal and emergency medicine · 2025
   Article
6. Changes in Helicobacter pylori Status in Patients Who Underwent Partial Gastrectomy for Gastric Cancer Therapy.The Korean journal of helicobacter and upper gastrointestinal research · 2025
   Article
7. Anti-Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy.JAMA network open · 2024
   Article
8. Modeling and optimization of culture media for recombinantFrontiers in bioengineering and biotechnology · 2024
   Article
9. Changing trends in the epidemiology of gastric cancer.Medicine and pharmacy reports · 2023
   Review
10. Helicobacter pylori infection.Nature reviews. Disease primers · 2023
    Review
11. Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.World journal of gastrointestinal oncology · 2023
    Review
12. Effect ofJournal of clinical medicine · 2023
    Article
13. Worldwide Prevalence and Risk Factors ofChildren (Basel, Switzerland) · 2022
    Review
14. Helicobacter pylori and gastric cancer: a lysosomal protease perspective.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Review
15. Chinese Consensus Report on Family-BasedGut · 2022
    Article
16. The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer.Frontiers in immunology · 2022
    Review
17. Cost-effectiveness modelling of use of urea breath test for the management ofBMJ open gastroenterology · 2021
    Article
18. CD90 affects the biological behavior and energy metabolism level of gastric cancer cells by targeting the PI3K/AKT/HIF-1α signaling pathway.Oncology letters · 2021
    Article
19. Precision Medicine Approaches to Prevent Gastric Cancer.Gut and liver · 2021
    Review
20. Association ofCanadian journal of gastroenterology & hepatology · 2021
    Review

Corrections and comments

• Comment on
  Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.2018

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as